Role of MRI in screening, diagnosis and management of breast cancer

Expert Review of Anticancer Therapy

Volumn 8, Issue 5, 2008, Pages 811-817

  Swayampakula, Anil Kumar ^a   Dillis, Charlotte ^a   Abraham, Jame ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Breast cancer; Chemotherapy; Diagnosis; Mammography; Management; MRI; Screening; Ultrasound

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST BIOPSY; BREAST CANCER; BREAST RECONSTRUCTION; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HIGH RISK PATIENT; HUMAN; IMAGING SYSTEM; MAMMOGRAPHY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SENSITIVITY AND SPECIFICITY; BREAST TUMOR; FEMALE; INSTRUMENTATION; MASS SCREENING; METHODOLOGY; PATHOLOGY;

BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 45849129821     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.8.5.811     Document Type: Review

References (39)

1. Gordon PB. Ultrasound for breast cancer screening and staging. Radiol. Clin. North Am. 40, 431-441 (2002).
2. Sardanelli F, Giuseppetti GM, Panizza P et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. Am. J. Roentgenol. 183, 1149-1157 (2004).
3. Provenzale JM. Imaging of angiogenesis: clinical techniques and novel imaging methods. Am. J. Roentgenol. 188, 11-23 (2007).
4. Burke W, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277, 997-1003 (1997).
5. Warner E, Plewes DB, Hill KA et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292, 1317-1325 (2004).
6. Lakhani SR, Jacquemier J, Sloane JP et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl Cancer Inst. 90, 1138-1145 (1998).
7. Neglia JP, Friedman DL, Yasui Y et al. Second malignant neoplasms in five-year survivors of childhood cancer. childhood cancer survivor study. J. Natl Cancer Inst. 93, 618-629 (2001).
8. Kenney LB, Yasui Y, Inskip PD et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann. Intern. Med. 141, 596-597 (2004).
9. Drew PJ, Chatterjee S, Turnbull LW et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann. Surg. Oncol. 6, 599-603 (1999).
10. Bedrosian I, Schlencker J, Spitz FR et al. Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions. Ann. Surg. Oncol. 9, 457-461 (2002).
11. Liberman L. Percutaneous image-guided core breast biopsy. Radiol. Clin. North Am. 40, 483-500 (2002).
12. Liberman L, Morris EA, Dershaw DD, Thornton CM, Van Zee KJ, Tan LK. Fast MRI-guided vacuum-assisted breast biopsys: initial experience. Am. J. Roentgenol. 181, 1283-1293 (2003).
13. Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann. Surg. Oncol. 12, 4045-1053 (2005).
14. Lee SG, Orel SG, Woo IJ et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226, 773-778 (2003).
15. Rodenko, GN, Harms SE, Pruneda JM et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. Am. J. Roentgenol. 167, 1415-149 (1996).
16. Gianfelice D, Khiat A, Boulanger Y, Amara M, Belblidia A. Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. J. Vasc. Interv. Radiol. 14, 1275-1282 (2003).
17. Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103, 2481-2484 (2005).
18. Esserman LJ, Kumar AS, Herrera AF et al. Magnetic resonance imaging captures the, biology of ductal carcinoma in situ. J. Clin. Oncol. 24, 4603-4610 (2006).
19. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging, Breast J. 11, 382-390 (2005).
20. Kuhl CK, Schrading S, Bieling HB et al. MRI for diagnosis of pure ductal carcinoma in situ: a Prospective observational study. Lancet 370, 485-492 (2007).
21. Orel SG, Dougherty CS, Reynolds C, Czerhiecki BJ, Siegelman ES, Schnall MD. MR imaging in patients with nipple discharge: initial experience. Radiology 216, 248-254 (2000).
22. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J. Clin. Oncol. 17, 110-119 (1999).
23. Hölmich LR, Vejborg I, Conrad C, Sletting S, McLaughlin JK. The diagnosis of breast implant rupture: MRI findings compared with findings at explantation. Eur. J. Radiol. 53, 213-225 (2005).
24. Scaranelo AM, Marques AF, Smialowski EB, Lederman HM. Evaluation of the rupture of silicone breast implants by mammography, ultrasonography and magnetic resonance imaging in asymptomatic patients: correlation with surgical findings. Sao Paulo Med. J. 122, 41-47 (2004).
25. Peng HL, Wu CC, Choi WM, Hui MS, Lu TN, Chen LK. Breast cancer detection using magnetic resonance imaging in breasts injected with liquid silicone. plast. Reconstr. Surg. 104, 2116-2120 (1999).
26. Tan JE, Orel SG, Schnall MD, Schultz DJ, Solin LJ. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage. breast cancer for breast conservation treatment. Am. J. Clin. Oncol. 22, 414-418 (1999).
27. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213, 881-888 (1999).
28. Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch. Surg. 142, 441-445 (2007).
29. Esserman L, Kaplan E, Partridge S et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann. Surg. Oncol. 8, 549-559 (2001).
30. Warren RM, Bobrow LG, Earl HM et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br. J. Cancer 90, 1349-1360 (2004).
31. Kinkel K, Hylton NM. Challenges to interpretation of breast MRI. J. Magn. Reson. Imaging. 13, 821-829 (2001).
32. Rieber A, Tomczak RJ, Merge, PJ, Wenzel V, Zeitler H, Brambs HJ. MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J. Comput. Assist. Tomogr. 21, 128-132 (1997).
33. Shah SK, Shah SK, Greatrex KV. Current role of magnetic resonance imaging in breast imaging: a primer for the primary care physician. J. Am. Board Fam. Pract. 18, 478-490 (2005).
34. Kacl GM, Liu P, Debatin JF, Garzoli E, Caduff RF, Krestin GP. Detection of breast cancer with conventional mammography and contrast-enhanced MR imaging. Eur. Radiol. 8, 194-200 (1998).
35. Henrik S. Thomsen. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur. Radiol. 16, 2619-2621 (2006)
36. Smith RA, Saslow D, Sawyer KA et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J. Clin. 53, 141-169 (2003).
37. Saslow D, Boetes C, Burke W et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J. Clin. 57, 75-89 (2007).
38. Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244, 356-378 (2007).
39. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244, 672-691 (2007).